KALA
Kala Pharmaceuticals Inc
-9.01%
$16.65 - $15.15
Feb 7th 2023 - Mar 21st 2023
COSM
Cosmos Holdings Inc
-39.30%
$5.00 - $3.04
Feb 7th 2023 - Mar 21st 2023
Jan, 13, 2023
They do have good financials (right now), low floa... See more
Jan, 13, 2023
$SMFL producing decent amount of revenue.
ARDX
Ardelyx Inc
23.58%
$3.35 - $4.14
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
Great pipe with sales ramping for revs and not lik... See more
Jan, 21, 2023
That means no additional manufacturing cost.
Dec, 28, 2022
With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.
Jan, 13, 2023
They do have good financials (right now), low float, low shorts, have increased potential market for their products without increasing expenses to produce.
Jan, 13, 2023
$SMFL producing decent amount of revenue.
Jan, 11, 2023
It has a variety of production lines that can produce solids, orals, semi solids and liquids.
Dec, 28, 2022
With SMFL Greens Line, manufacturing facility, and USA location makes perfect sense.
Dec, 28, 2022
With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.
Dec, 28, 2022
With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.
Dec, 28, 2022
With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.
Dec, 28, 2022
With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.
Dec, 28, 2022
THE PLAN With SMFL greens line, manufacturing facility, and USA presence makes perfect sense.
Dec, 23, 2022
$COSM "We love that CEO Siokas buys his own stock, and would be in a strategic position to manage Smart For Life's footprint and manufacturing in the USA to leverage Cosmos growth." Yes!
Mar, 17, 2023
Great pipe with sales ramping for revs and not likely to need to raise this year.
Jan, 21, 2023
That means no additional manufacturing cost.
Jan, 19, 2023
This should be seen as a REALLY good thing - because they will need cashflow soon - one would expect - assumption being FDA response is close and production and marketing is about to get kicked up a notch. .
Jan, 19, 2023
$ARDX I like how this stock was performing a perfect ramp up to parabolic breakout and then Raab kills all the momentum.
Nov, 3, 2022
Growth, EPS beat, lots of cash, reduced expenses, low manufacturing price, very healthy situation.
Oct, 4, 2022
No safety or manufacturing issues.